Lori A. Kunkel, M.D.

Lori A. Kunkel, M.D.

DirectoratNurix Therapeutics· In proxies 2023–2025

Lori A. Kunkel, M.D. sits on 8 public boards.

Boards1

  • Nurix TherapeuticsDirector · 4 yr on the boardIndependentCompensation, Development Advisory (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Nurix TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +129%
  2. Enliven Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. K36 Therapeutics, IncPublic company
    • Director? – PresentNo stock prices for these years
  4. Oric Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Curis, Inc.Public company · 6 yr
    • Director2016 – 2022 · 6 yrNo stock prices for these years
  6. Maverick TherapeuticsPublic company · 6 yr
    • Director2015 – 2021 · 6 yrNo stock prices for these years
  7. Tocagen Inc.Public company · 5 yr
    • Director2015 – 2020 · 5 yrNo stock prices for these years
  8. Loxo Oncology, Inc.Public company · 5 yr
    • Director2014 – 2019 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?